Collateral for a security interest recorded Sep 7, 2023 (Morgan Stanley Senior Funding, Inc.).
Term ended Nov 4, 2023 · High confidence
20-year base term ended Nov 4, 2023
Held by Insulet Corporation
Filed Dec 5, 2012 as application 13/705,638 · Granted Aug 12, 2014
Base term, 20 years from filing
Today
Term ended Nov 4, 2023
2003
2026
Clock starts
Nov 4, 2003
Nov 4, 2003
Term ended
Nov 4, 2023
Nov 4, 2023
Granted
Aug 12, 2014
Aug 12, 2014
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,469,920, to Nov 4, 2023. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 4, 2003, when application PCT/DK2003/000753, the earliest non-provisional in its chain, was filed (this one was filed Dec 5, 2012) | Nov 4, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,469,920) | resolves to Nov 4, 2023, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 4, 2023 | High confidence |
This family
| US 7,887,511 | In force May 2028 | May 2028 |
| US 7,785,288 | In force Oct 2027 | Oct 2027 |
| US 8,469,920 | Term ended Jan 2025 | Jan 2025 |
| US 8,795,233 | Term ended Jan 2026 | Jan 2026 |
| US 8,801,655 | this patent Nov 2023 | Nov 2023 |
| US 9,295,777 | Term ended no later than Nov 2023 | no later than Nov 2023 |
| US 9,308,319 | Term ended no later than Nov 2023 | no later than Nov 2023 |
| US 9,757,512 | Term ended Nov 2023 | Nov 2023 |
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 6, 2013 Reel 29766, frame 516 | Mernoe, Morten; Lyngsie, Michael Gorm | M2 Medical A/S | Assignment of Assignor's Interest |
| Feb 7, 2013 Reel 29769, frame 303 | M2 Medical A/S | M2 Group Holdings, Inc. | Assignment of Assignor's Interest |
| Feb 7, 2013 Reel 29770, frame 988 | M2 Group Holdings, Inc. | Asante Solutions, Inc. | Change of Name |
| Jul 2, 2015 Reel 36047, frame 389 | Asante LLC | Bigfoot Biomedical, Inc. | Assignment of Assignor's Interest |
| Jul 2, 2015 Reel 36049, frame 175 | Asante Solutions, Inc. | Asante LLC | Assignment of Assignor's Interest |
| Mar 12, 2021 Reel 55583, frame 44 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Feb 10, 2023 Reel 62702, frame 145 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Feb 17, 2023 Reel 62793, frame 316 | Madryn Fund Administration, LLC | Bigfoot Biomedical, Inc. | Release of Security Interest |
| Jun 7, 2023 Reel 63909, frame 826 | Bigfoot Biomedical, Inc. | Insulet Corporation | Assignment of Assignor's Interest |
| Sep 7, 2023 Reel 64840, frame 181 | Insulet Corporation | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Security Agreement Supplement |
| Sep 12, 2024 Reel 68948, frame 172 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Sep 12, 2024 Reel 68948, frame 324 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Sep 23, 2024 Reel 69019, frame 142 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Sep 23, 2024 Reel 69019, frame 188 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Sep 24, 2024 Reel 69030, frame 104 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Sep 24, 2024 Reel 69030, frame 296 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Sep 30, 2024 Reel 69073, frame 912 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Sep 30, 2024 Reel 69074, frame 1 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
| Jan 10, 2025 Reel 69870, frame 456 | Bigfoot Biomedical, Inc. | Madryn Health Partners, LP | Security Interest |
| Jan 10, 2025 Reel 69870, frame 519 | Madryn Health Partners, LP | Madryn Fund Administration, LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,469,920, ends no earlier than this term, so it caps nothing.
Citations
15
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.